This is the Arizona-specific framework that most out-of-state training programs never mention, and it is the one investigators actually reference. If you inject in this state under delegation, the tier your procedure falls into determines what your paperwork and your emergency kit must contain.
The two tiers
| Level II | Level III | |
|---|---|---|
| Typical procedures | Neuromodulators — Botox, Dysport, Xeomin, Jeuveau | Dermal fillers — HA and non-HA |
| Primary risk | Diffusion, asymmetry, ptosis — usually temporary | Vascular occlusion — tissue necrosis, rarely vision loss |
| Written prescriber order | Required | Required |
| Good-faith exam | Required | Required |
| Zone-specific authorization | Recommended | Expected |
| Written vascular-emergency protocol | Not specifically required | Required |
| Hyaluronidase on site | Not applicable | Required for HA filler |
| Reversibility | Not reversible; effects wear off | HA filler is reversible with hyaluronidase |
Why filler sits in the higher tier
The distinction is not about difficulty or how the result looks. It is about what happens in the worst realistic case and how fast someone must act.
A poor neuromodulator outcome is distressing and it resolves. A dose placed too close to the levator can drop an eyelid for weeks, and that is genuinely bad, but it is temporary and it is not an emergency.
Filler injected into a vessel is different in kind. Blood supply to an area of tissue is obstructed, and without prompt recognition and treatment that tissue can die. Injection near the glabella, nose, or nasolabial region carries a rare but documented risk of vision loss. The window for intervention is measured in hours, which is precisely why the Board expects the plan to exist in writing before the event rather than being improvised during it.
A practice trains its RN on Botox, writes a standing order for neuromodulators, and later adds filler to the menu without revisiting a single document. The order never mentions filler or zones, no vascular-emergency protocol exists, and there is no hyaluronidase in the building. That is the exact gap that turns a manageable complication into a board matter and a denied insurance claim.
What Level III actually obliges you to have
- Zone-specific written authorization. Which regions the injector may treat, named individually.
- A written vascular-emergency protocol. Recognition signs, immediate steps, hyaluronidase dosing, and who to call — specific enough to follow under pressure.
- Hyaluronidase on site and in date. Not orderable, not at the other location. Present, and checked.
- Trained staff. Injectors who can recognize blanching, disproportionate pain, and livedo reticularis for what they are.
- A documented escalation path. Including ophthalmology contact for periocular work and an after-hours route.
How the tiers interact with delegation
These classifications only matter where a procedure is being performed as a delegated medical act — that is, by a nurse under a prescriber's authority. They set the standard your standing order must meet, and for Level III they are the reason a vascular occlusion protocol is not optional.
Arizona notably does not require the prescriber to stand in the room for Level II work. That flexibility is real and useful. It is also frequently over-read into Level III, where the absence of a presence requirement does not lessen the obligation to be genuinely prepared.
Frequently asked
Which procedures are Level II and which are Level III?
Neuromodulators such as Botox, Dysport, Xeomin, and Jeuveau are treated as Level II. Dermal fillers are treated as Level III because an intravascular injection can obstruct blood supply and cause tissue necrosis or, rarely, visual loss. The distinction tracks the severity and immediacy of the worst realistic complication.
Does Level III require the prescriber to be physically on site?
Arizona does not impose a blanket physical-presence rule. What Level III does require is a materially higher standard of preparation: a written vascular-emergency protocol, hyaluronidase immediately available, staff trained to recognize occlusion, and a documented escalation path. Practically, a practice that cannot meet those conditions should not be running filler unsupervised.
Where does this classification come from?
It comes from Arizona State Board of Nursing advisory guidance rather than from a statute that lists procedures by name. Advisory opinions are how the Board communicates its interpretation of the Nurse Practice Act, and investigators cite them when evaluating whether delegation was appropriate.
Do these levels apply to NPs and PAs?
The classification governs delegation to nurses, so it bears most directly on RN injectors. An NP working within full practice authority is not operating under delegation at all. That said, the underlying safety expectations — recognizing occlusion, having hyaluronidase available, documenting a protocol — are clinical standards that apply to any injector regardless of credential.
What about threads, lasers, and PRP?
Those are evaluated on the same logic rather than appearing on a fixed list. The questions are how severe the foreseeable complication is, how quickly it must be recognized, and how much independent judgment the procedure demands. Treatments with serious, fast-moving complications are handled with Level III-style preparation regardless of label.